Dr. Martens Past Earnings Performance
Past criteria checks 2/6
Dr. Martens has been growing earnings at an average annual rate of 38%, while the Luxury industry saw earnings growing at 27.7% annually. Revenues have been growing at an average rate of 16.9% per year. Dr. Martens's return on equity is 31.9%, and it has net margins of 12.9%.
Key information
38.0%
Earnings growth rate
37.8%
EPS growth rate
| Luxury Industry Growth | 12.9% |
| Revenue growth rate | 16.9% |
| Return on equity | 31.9% |
| Net Margin | 12.9% |
| Next Earnings Update | 30 Nov 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Dr. Martens makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 23 | 1,000 | 129 | 373 | 0 |
| 31 Dec 22 | 979 | 153 | 350 | 0 |
| 30 Sep 22 | 957 | 177 | 347 | 0 |
| 30 Jun 22 | 933 | 179 | 331 | 0 |
| 31 Mar 22 | 908 | 181 | 316 | 0 |
| 31 Dec 21 | 867 | 118 | 300 | 0 |
| 30 Sep 21 | 825 | 54 | 304 | 0 |
| 30 Jun 21 | 799 | 44 | 276 | 0 |
| 31 Mar 21 | 773 | 35 | 248 | 0 |
| 31 Dec 20 | 747 | 61 | 219 | 0 |
| 30 Sep 20 | 722 | 87 | 191 | 0 |
| 30 Jun 20 | 697 | 81 | 204 | 0 |
| 31 Mar 20 | 672 | 75 | 217 | 0 |
| 31 Mar 19 | 454 | 17 | 124 | 0 |
| 31 Mar 18 | 349 | -6 | 94 | 0 |
| 31 Mar 17 | 291 | -11 | 75 | 0 |
| 31 Mar 16 | 232 | -12 | 56 | 0 |
| 31 Mar 15 | 235 | 0 | 50 | 0 |
| 31 Mar 14 | 164 | -32 | 24 | 0 |
Quality Earnings: DOCS N has a high level of non-cash earnings.
Growing Profit Margin: DOCS N's current net profit margins (12.9%) are lower than last year (19.9%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DOCS N has become profitable over the past 5 years, growing earnings by 38% per year.
Accelerating Growth: DOCS N's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DOCS N had negative earnings growth (-28.9%) over the past year, making it difficult to compare to the Luxury industry average (-13%).
Return on Equity
High ROE: DOCS N's Return on Equity (31.9%) is considered high.